A Study of Fully Human BCMA Chimeric Antigen Receptor Autologous T Cell Injection (CT103A) in the Treatment of Patients With Relapsed/Refractory Multiple Myeloma
Condition(s):Multiple MyelomaLast Updated:January 26, 2023Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):Multiple MyelomaLast Updated:January 26, 2023Not yet recruiting
Condition(s):Multiple MyelomaLast Updated:January 6, 2022Not yet recruiting
Condition(s):Extramedullary Multiple MyelomaLast Updated:May 24, 2022Recruiting
Condition(s):Multiple MyelomaLast Updated:November 23, 2021Recruiting
Condition(s):Autoimmune Diseases; Autoimmune Diseases of the Nervous System; Neuromyelitis Optica Spectrum Disorder; Myasthenia Gravis; Chronic Inflammatory Demyelinating Polyradiculoneuropathy; Immune-Mediated Necrotizing MyopathyLast Updated:April 12, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.